Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I Clemmensen

Showing results (21-30 of 95) with videos related to

Pageof 10
Sort By:
The Biochemical Journal|October 1, 1981
Kinetics of plasmin inhibition in the presence of a synthetic tripeptide substrate. The reaction with pancreatic trypsin inhibitor and two forms of alpha 2-plasmin inhibitorL C Petersen, I Clemmensen
Seminars in Arthritis and Rheumatism|May 1, 1982
The fibrinolytic system and its relation to inflammatory diseasesI Clemmensen, R B Andersen
Arthritis and Rheumatism|January 1, 1982
Different molecular forms of fibronectin in rheumatoid synovial fluidI Clemmensen, R B Andersen
The Biochemical Journal|March 1, 1982
A fibronectin-binding glycoprotein from human platelet membranesM S Hansen, I Clemmensen
The New England Journal of Medicine|April 3, 1980
Use of thrombolytic agentsM S Hansen, I Clemmensen
The Journal of Laboratory and Clinical Medicine|November 1, 1978
Properties of fibrinogen-antigenic material on the rheumatoid synovial membrane and in the rheumatoid synovial fluidI Clemmensen, R B Andersen
Journal of Clinical & Laboratory Immunology|November 1, 1986
Identification and quantification of a monoclonal IgM euglobulin: pitfalls and methodologic instructionB A Jensen, I Clemmensen
The Biochemical Journal|April 1, 1980
Partial purification and characterization of a new fast-acting plasmin inhibitor from human platelets. Evidence for non-identity with the known plasma proteinase inhibitorsM Sandbjerg Hansen, I Clemmensen
Cancer|September 1, 1988
Plasma tetranectin is reduced in cancer and related to metastasiaB A Jensen, I Clemmensen
Scandinavian Journal of Immunology|January 1, 1993
Tetranectin: a novel secretory protein from human monocytesH Nielsen, I Clemmensen, A Kharazmi
Pageof 10

Showing results (21-30 of 95) with videos related to

Sort By:
Pageof 10
The Biochemical Journal|October 1, 1981
Kinetics of plasmin inhibition in the presence of a synthetic tripeptide substrate. The reaction with pancreatic trypsin inhibitor and two forms of alpha 2-plasmin inhibitorL C Petersen, I Clemmensen
Seminars in Arthritis and Rheumatism|May 1, 1982
The fibrinolytic system and its relation to inflammatory diseasesI Clemmensen, R B Andersen
Arthritis and Rheumatism|January 1, 1982
Different molecular forms of fibronectin in rheumatoid synovial fluidI Clemmensen, R B Andersen
The Biochemical Journal|March 1, 1982
A fibronectin-binding glycoprotein from human platelet membranesM S Hansen, I Clemmensen
The New England Journal of Medicine|April 3, 1980
Use of thrombolytic agentsM S Hansen, I Clemmensen
The Journal of Laboratory and Clinical Medicine|November 1, 1978
Properties of fibrinogen-antigenic material on the rheumatoid synovial membrane and in the rheumatoid synovial fluidI Clemmensen, R B Andersen
Journal of Clinical & Laboratory Immunology|November 1, 1986
Identification and quantification of a monoclonal IgM euglobulin: pitfalls and methodologic instructionB A Jensen, I Clemmensen
The Biochemical Journal|April 1, 1980
Partial purification and characterization of a new fast-acting plasmin inhibitor from human platelets. Evidence for non-identity with the known plasma proteinase inhibitorsM Sandbjerg Hansen, I Clemmensen
Cancer|September 1, 1988
Plasma tetranectin is reduced in cancer and related to metastasiaB A Jensen, I Clemmensen
Scandinavian Journal of Immunology|January 1, 1993
Tetranectin: a novel secretory protein from human monocytesH Nielsen, I Clemmensen, A Kharazmi
Pageof 10